IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 81 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $122,000 | +29.8% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $94,000 | +8.0% | 54,700 | +55.8% | 0.00% | 0.0% |
| Q1 2017 | $87,000 | +67.3% | 35,100 | +1.4% | 0.00% | – |
| Q4 2016 | $52,000 | -41.6% | 34,600 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $89,000 | +67.9% | 34,600 | 0.0% | 0.00% | – |
| Q2 2016 | $53,000 | +8.2% | 34,600 | +40.7% | 0.00% | – |
| Q1 2016 | $49,000 | +8.9% | 24,600 | +68.5% | 0.00% | – |
| Q4 2015 | $45,000 | +7.1% | 14,600 | +15.9% | 0.00% | – |
| Q3 2015 | $42,000 | -35.4% | 12,600 | -28.4% | 0.00% | -100.0% |
| Q2 2015 | $65,000 | 0.0% | 17,600 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $65,000 | +14.0% | 17,600 | +27.1% | 0.00% | 0.0% |
| Q1 2014 | $57,000 | – | 13,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
| Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
| HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
| EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
| Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
| Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
| CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
| NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |